Concepedia

Gilles Buchwalter

GB

Statistics

Publications

16

Citations

1.8K

H-Index

16

Active since

2001

Affiliations

Dana-Farber Cancer Institute(Current)

Institut de génétique et de biologie moléculaire et cellulaire

Centre National de la Recherche Scientifique

Inserm

Harvard University

Gilles Buchwalter is an author at Dana-Farber Cancer Institute specializing in oncology, molecular oncology, and medicine.

Publications per year

2001–2018

16

Publications

16

Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer

Rinath Jeselsohn, Roman Yelensky, Gilles Buchwalter et al. · Clinical Cancer Research · 2014 · 662 citations

, , +17

Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations

Rinath Jeselsohn, Johann S. Bergholz, Matthew Pun et al. · Cancer Cell · 2018 · 282 citations · Full text

, , +16

Net‐targeted mutant mice develop a vascular phenotype and up‐regulate egr‐1

A. Ayadi, Hong Zheng, Peter Sobieszczuk et al. · The EMBO Journal · 2001 · 124 citations · Full text

, , +10

Embryonic transcription factor SOX9 drives breast cancer endocrine resistance

Rinath Jeselsohn, MacIntosh Cornwell, Matthew Pun et al. · Proceedings of the National Academy of Sciences · 2017 · 114 citations · Full text

, , +17

The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells

Sean W. Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan et al. · eLife · 2018 · 94 citations · Full text

, , +15

1–5 of 16